- Article
RETRACTED: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis
- Anna-Maria Wiesinger,
- Brian Bigger,
- Roberto Giugliani,
- Christina Lampe,
- Maurizio Scarpa,
- Tobias Moser,
- Christoph Kampmann,
- Georg Zimmermann and
- Florian B. Lagler
Mucopolysaccharidosis (MPS) is a group of rare metabolic diseases associated with reduced life expectancy and a substantial unmet medical need. Immunomodulatory drugs could be a relevant treatment approach for MPS patients, although they are not lice...

